Package 43063-998-60

{"route": ["ORAL"], "spl_id": "3a22cbea-53cc-4e02-e063-6294a90aef45", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0343063998304"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["021005ab-6a00-40d8-9aee-20c91613b4d5"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-998-30)", "package_ndc": "43063-998-30", "marketing_start_date": "20190808"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-998-60)", "package_ndc": "43063-998-60", "marketing_start_date": "20190730"}], "brand_name": "Topiramate", "product_id": "43063-998_3a22cbea-53cc-4e02-e063-6294a90aef45", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "43063-998", "generic_name": "Topiramate", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA090278", "marketing_category": "ANDA", "marketing_start_date": "20141215", "listing_expiration_date": "20261231"}